329
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Patient and Provider Perspectives on Medication Non-adherence Among Patients with Depression and/or Diabetes in Diverse Community Settings – A Qualitative Analysis

, , , , , ORCID Icon, ORCID Icon & show all
Pages 1581-1594 | Published online: 30 Jun 2022

References

  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
  • Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657–665. doi:10.1093/ajhp/60.7.657
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2008:CD000011.
  • Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795. doi:10.7326/0003-4819-157-11-201212040-00538
  • Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224. doi:10.2337/diacare.27.5.1218
  • Aronson BD, Sittner KJ, Walls ML. The mediating role of diabetes distress and depressive symptoms in type 2 diabetes medication adherence gender differences. Health Educ Behav. 2020;47(3):474–482. doi:10.1177/1090198119885416
  • Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–2403. doi:10.2337/dc08-1341
  • Edward A, Campbell B, Manase F, Appel LJ. Patient and healthcare provider perspectives on adherence with antihypertensive medications: an exploratory qualitative study in Tanzania. BMC Health Serv Res. 2021;21(1):834. doi:10.1186/s12913-021-06858-7
  • van Boven JF, Stuurman-Bieze AG, Hiddink EG, Postma MJ, Vegter S. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Pharm. 2014;20(8):786–792. doi:10.18553/jmcp.2014.20.8.786
  • Kangovi S, Mitra N, Grande D, et al. Patient-centered community health worker intervention to improve posthospital outcomes: a randomized clinical trial. JAMA Intern Med. 2014;174(4):535–543. doi:10.1001/jamainternmed.2013.14327
  • Bosworth HB, Fortmann SP, Kuntz J, et al. Recommendations for providers on person-centered approaches to assess and improve medication adherence. J Gen Intern Med. 2017;32(1):93–100. doi:10.1007/s11606-016-3851-7
  • Hodges JR, Phillips SM, Norell S, et al. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study [published correction appears in Blood Adv. 2020 Oct 13;4(19):4822]. Blood Adv. 2020;4(18):4463–4473. doi:10.1182/bloodadvances.2020001701
  • Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007;44(8):1468–1477. doi:10.1016/j.ijnurstu.2006.07.010
  • Fan JH, Lyons SA, Goodman MS, Blanchard MS, Kaphingst KA. Relationship between health literacy and unintentional and intentional medication nonadherence in medically underserved patients with type 2 diabetes. Diabetes Educ. 2016;42(2):199–208. doi:10.1177/0145721715624969
  • Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional non-adherence, and intentional non-adherers: application of the necessity–concerns framework. J Psychosom Res. 2008;64:41–46. doi:10.1016/j.jpsychores.2007.05.004
  • Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005;39(7–8):1198–1203. doi:10.1345/aph.1E594
  • DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209. doi:10.1097/01.mlr.0000114908.90348.f9
  • DiMatteo MR, Haskard-Zolnierek KB, Martin LR. Improving patient adherence: a three-factor model to guide practice. Health Psychol Rev. 2012;6:74–91.
  • French DP, Wade AN, Farmer AJ. Predicting self-care behaviours of patients with type 2 diabetes: the importance of beliefs about behaviour, not just beliefs about illness. J Psychosom Res. 2013;74:327–333. doi:10.1016/j.jpsychores.2012.12.008
  • Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity–concerns framework. PLoS One. 2013;8:e80633.
  • Kleinsinger F. The unmet challenge of medication nonadherence. Perm J. 2018;22:18–033. doi:10.7812/TPP/18-033
  • Jaam M, Hadi MA, Kheir N, et al. A qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Qatar: integrating perspectives of patients and health care providers. Patient Prefer Adherence. 2018;12:2205–2216. doi:10.2147/PPA.S174652
  • Glaser BG, Strauss AL. The Discovery of Grounded Theory. Strategies for Qualitative Research. Chicago: Aldine; 1967.
  • Glaser BG. Doing Grounded Theory: Issues and Discussions. Mill Valley, CA: Sociology Press; 1998.
  • Powell RA, Single HM. Focus groups. Int J Qual Health Care. 1996;8(5):499–504. doi:10.1093/intqhc/8.5.499
  • Wong LP. Focus group discussion: a tool for health and medical research. Singapore Med J. 2008;49(3):256–60;quiz 261.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi:10.1191/1478088706qp063oa
  • Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117. doi:10.1186/1471-2288-13-117
  • Birt L, Scott S, Cavers D, Campbell C, Walter F. Member checking: a tool to enhance trustworthiness or merely a nod to validation? Qual Health Res. 2016;26(13):1802–1811. doi:10.1177/1049732316654870
  • Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–834. doi:10.1097/MLR.0b013e31819a5acc
  • Jolles EP, Clark AM, Braam B. Getting the message across: opportunities and obstacles in effective communication in hypertension care. J Hypertens. 2012;30(8):1500–1510. doi:10.1097/HJH.0b013e32835476e1
  • Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: a meta-analytic review. JAMA. 2002;288(6):756–764.
  • Yen PH, Leasure AR. Use and effectiveness of the teach-back method in patient education and health outcomes. Federal Practition. 2019;36(6):284–289.
  • Schillinger D. Association of health literacy with diabetes outcomes. JAMA. 2002;288(4):475. doi:10.1001/jama.288.4.475
  • Nielsen-Bohlman L, editor. Institute of Medicine (U.S.) Health Literacy: A Prescription to End Confusion. Washington, D.C: National Academies Press; 2004.
  • Bauer AM, Schillinger D, Parker MM, et al. Health literacy and antidepressant medication adherence among adults with diabetes: the diabetes study of Northern California (DISTANCE). J Gen Intern Med. 2013;28(9):1181–1187. doi:10.1007/s11606-013-2402-8
  • Upadhyai R, Jain AK, Roy H, Pant V. Participants’ perspectives on healthcare service quality in multispecialty hospitals: a qualitative approach. J Health Manag. 2020;22(3):446–465. doi:10.1177/0972063420938471
  • Hopwood M. The shared decision-making process in the pharmacological management of depression. Patient. 2020;13(1):23–30. doi:10.1007/s40271-019-00383-w
  • Peek ME, Gorawara-Bhat R, Quinn MT, Odoms-Young A, Wilson SC, Chin MH. Patient trust in physicians and shared decision-making among African-Americans with diabetes. Health Commun. 2013;28(6):616–623. doi:10.1080/10410236.2012.710873
  • Chan AHY, Cooper V, Lycett H, Horne R. Practical barriers to medication adherence: what do current self- or observer-reported instruments assess? Front Pharmacol. 2020;11:572. doi:10.3389/fphar.2020.00572
  • Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:10.1080/08870449908407311
  • Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–871. doi:10.1007/s11606-007-0180-x
  • Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149. doi:10.1186/1471-2288-11-149
  • Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18(5):401–409. doi:10.1089/10807680260362687
  • Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–199.
  • Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183. doi:10.1371/journal.pmed.1002183
  • Jamison J, Sutton S, Mant J, De Simoni A. Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum. BMJ Open. 2017;7(7):e016814. doi:10.1136/bmjopen-2017-016814
  • Velligan DI, Diamond PM, Mintz J, et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull. 2008;34(3):483–493. doi:10.1093/schbul/sbm111
  • Velligan DI, Bow-Thomas CC, Huntzinger C, et al. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. Am J Psychiatry. 2000;157(8):1317–1323. doi:10.1176/appi.ajp.157.8.1317
  • Velligan DI, Prihoda TJ, Ritch JL, Maples N, Bow-Thomas CC, Dassori A. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophr Bull. 2002;28(2):283–292. doi:10.1093/oxfordjournals.schbul.a006938
  • Velligan DI, Gonzalez JM. Rehabilitation and recovery in schizophrenia. Psychiatr Clin North Am. 2007;30(3):535–548. doi:10.1016/j.psc.2007.05.001
  • Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract. 2011;61(583):83–84. doi:10.3399/bjgp11X556146
  • Stack RJ, Bundy CE, Elliott RA, New JP, Gibson M, Noyce PR. Intentional and unintentional non-adherence in community dwelling people with type 2 diabetes: the effect of varying numbers of medicines. Br J Diabetes Vasc Dis. 2010;10(3):148–152. doi:10.1177/1474651409357034
  • Robles-Martinez P, Xu X, Trenfield SJ, et al. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics. 2019;11(6):274. doi:10.3390/pharmaceutics11060274